shallaki :
Clinical trials:
1.- Ammon HP. Salaiguggul-Boswelliaserrata from a herbal medicine to a specific inhibitor of leukotriene biosynthesis. Phytomedicine 1996;3:67-70.
2.
- Etzel R. Special extract of boswelliaserrata (H15) in the treatment of rheumatoid arthritis. Phytomedicine 1996;3:91-4.
3. Pardhy RS, Bhattacharyya SC. β-Boswellic acid, acetyl- β-boswellic acid, acetyl-11-keto-β-boswellic acid and 11-keto-β-boswellic acid, four pentacyclictriterpenic acids from the resin of BoswelliaserrataRoxb. Indian J Chem 1978;16B:176-8.
Research:
1. Basch E, Boon H, Davies T, Hashmi S, Hasskari J, Sollars D, et al. Boswellia: A evidence based systematic review by the naturalstandard research collaboration. J Herb Phar 2004;4:63-83- Pawar RK, Sharma S, Singh KC, Sharma RK. Physico-chemical standardization and development of HPTLC method for the determination of β-boswellic acid from BoswelliaserrataRoxb. (exudate). Int J App Pharm 2011;3:8-13.
- Singh GB, Atal CK. Pharmacology of an extract of salaiguggul ex-Boswelliaserrata. Indian J Pharmacol 1984;16:51.
- » Classification and names of shallaki
- » Synonyms and definitions of shallaki
- » Drug Properties of shallaki
- » Chemical Constituents of shallaki
- » Standardization of shallaki
- » Parts used and Dosage of shallaki
- » Morphology and Histology of shallaki
- » Distribution and Conservation of shallaki
- » Cultivation of shallaki
- » shallaki in the market
- » Medicinal Uses of shallaki
- » Researches and clinical trails of shallaki
- » shallaki in other sytems of medicine
- » Ayurvedic formulations with shallaki
- » Images of shallaki
